According to Horizon Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 228,743,143. At the end of 2023 the company had 228,743,143 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.22 B | 0.78% |
2022 | 0.22 B | -0.03% |
2021 | 0.22 B | 2.91% |
2020 | 0.22 B | 18.7% |
2019 | 0.18 B | 11.59% |
2018 | 0.16 B | 1.53% |
2017 | 0.16 B | 1.66% |
2016 | 0.16 B | 1.16% |
2015 | 0.15 B | 37.91% |
2014 | 0.11 B | 77.62% |
2013 | 65.12 M | 5.51% |
2012 | 61.72 M | 214.46% |
2011 | 19.62 M | 1211.77% |
2010 | 1.49 M | 0% |
2009 | 1.49 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 2,368.71% | ๐บ๐ธ USA |
Amgen AMGN | 535,000,000 | 133.89% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 1,016.61% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 1,254.36% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | 166,513,706 | -27.20% | ๐ฎ๐ณ India |